Aller au contenu

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer.

Nom du journal : Gynecol Oncol

Année : 2023

Volume : 170

Page de départ : 221-228

Auteurs: Davidson, TM, Lebreton, CL, Hendricksen, AEW, Atkinson, HJ, Larson, MC, Oberg, AL & al,